Pharma News

Pfizer released its 2021 financial report, in which the revenue of Comirnaty, the mRNA new crown vaccine jointly developed by Pfizer and BioNTech, reached a record $36.781 billion, making it the “King of Medicines”.

• drug king
• Pfizer
• Cosmic factory

With the rapid development of life sciences, the beginning of the biological age is slowly unfolding, and this trend is also reflected in the growing content of biological sequences in CAS REGISTRY.

• biological
• compound
• Moderna

Sulfonamide products run smoothly, and product prices are high. Asia Pacific Yihe Data Analysis Center focuses on products

• Veterinary
• Sulfonamides
• Quinolones

Ceftiofur sodium, ceftiofur hydrochloride, affected by the production restriction and suspension of Beijing Winter Olympics, the price is strong, ceftiofur sodium 2350, ceftiofur hydrochloride 1700

• veterinary drug
• Aminoglycosides
• Tetracyclines

This product is an oral small-molecule novel coronavirus treatment drug for the treatment of adults with mild to moderate novel coronavirus pneumonia (COVID-19) with high risk factors for progression to severe disease.

• Paxlovid
• Pfizer
• pfizer news

Theoretically, all chemical substances that can affect the organs, physiological functions and cellular metabolic activities of the body belong to the category of drugs.

• dietary supplement
• Drugs
• pharmaceutical trend

VPI is stable, the market restarts slowly after the holiday, and a wait-and-see mentality is strong, waiting for changes in the market to choose.

• veterinary
• Florfenicol

Penicillin industrial salt - quotations from mainstream factories are high, market inquiries increase after the holiday, and trade transaction prices are broad (transaction 115-145 yuan/billion).

• Tetracyclines
• antibiotics
• Quinolones

According to the "China Raw Material Drug Sodium Bicarbonate Market Forecast and Investment Strategy Report (2022 Edition)" released by Limu Information Consulting

• API
• Sodium bicarbonate

On February 10, AstraZeneca announced its 2021 results. For the full year, the company achieved revenue of $37.417 billion, an increase of 41% year-over-year.

• AstraZeneca
• 2021 results
• Osimertinib

The elderly are the main incidence group of hypertension, and the reasonable selection of antihypertensive drugs is an effective measure to prevent and slow down the occurrence of cardiovascular and cerebrovascular complications in the elderly.

• blood pressure
• food health
• Pill

Among them, mitral valve and tricuspid valve interventional therapy is a hot track for artificial heart valve research and development companies in recent years.

• heart disease
• pharmaceutical policy
• Health

On January 20, local time, the Medicines Patent Pool (MPP) announced through its official website that it has signed agreements with 27 pharmaceutical companies to allow them to produce and supply Merck’s oral anti-new coronavirus drug

• Merck
• oral drugs
• COVID-19

Data monitoring, on January 19, the veterinary drug raw material price index (VPi) was 90.15.

• pharmaceutical

Ceftiofur sodium, ceftiofur hydrochloride, in January 2022, the market is stable, the market price of ceftiofur sodium 2380, ceftiofur hydrochloride 1600

• pharmaceutical
• API

Recently, Clarivate Analytics analysts released a list of drugs predicted to be "blockbusters" in the future.

• population
• Drug

On January 4, Nature magazine made an inventory of new drugs approved by the US FDA in 2021, and made sales forecasts. In addition, statistics have been made on new drugs that will be approved in 2022.

• FDA covid 19

At the beginning of 2021, due to the impact of the new crown epidemic in Hebei, amoxicillin started the first round of price increases, and the price rose close to 200.

• veterinary drug
• vitamin
• pharmaceutical

Entering the new year, various varieties of veterinary drug raw materials have continued to decline. Among the veterinary drug raw materials monitored by the China Veterinary Drug and Feed Trading Center, florfenicol has led the decline.

• Florfenicol
• Tilmicosin

Ashwagandha, in fact, is a local herb native to India and is readily available. It is recognized for its significant antioxidant and immune-boosting properties. In addition, it has been used to induce sleep.

• raw material
• immunity improvement
• APIs